Corrigendum: Persisting Cryptococcus yeast species Vishniacozyma victoriae and Cryptococcus neoformans elicit unique airway inflammation in mice following repeated exposure

[This corrects the article DOI: 10.3389/fcimb.2023.1067475.].

Vishniacozyma victoriae: An endophytic antagonist yeast of kiwifruit with biocontrol effect to Botrytis cinerea

Botrytis cinerea is a pathogenic fungus to fruit, biocontrol is a promising approach to relieve this issue. In this study, Vishniacozyma victoriae is an endophytic yeast extracted from kiwifruit, was used to enhance the resistance of host to B. cinerea. The results showed that lesion diameter of the kiwifruit inoculated with B. cinerea was 55.16 %, 50.57 %, and 48.07 % lower than that of inoculated with V. victoriae + B. cinerea on 4th, 8th, and 12th day, respectively. On 12th day, the total organic acid content and energy charge of kiwifruit inoculated with B. cinerea were 19.25 % and 7.95 % lower than those inoculated with V. victoriae + B. cinerea. These indicated that V. victoriae used the organic acids and energy of host to colonize in the wound, which prevented B. cinerea from contacting the host. Accordingly, V. victoriae is a promising biocontrol yeast to inhibit the infection of B. cinerea on kiwifruit.

Persisting Cryptococcus yeast species Vishniacozyma victoriae and Cryptococcus neoformans elicit unique airway inflammation in mice following repeated exposure

Background

Allergic airway disease (AAD) is a growing concern in industrialized nations and can be influenced by fungal exposures. Basidiomycota yeast species such as Cryptococcus neoformans are known to exacerbate allergic airway disease; however, recent indoor assessments have identified other Basidiomycota yeasts, including Vishniacozyma victoriae (syn. Cryptococcus victoriae), to be prevalent and potentially associated with asthma. Until now, the murine pulmonary immune response to repeated V. victoriae exposure was previously unexplored.

Objective

This study aimed to compare the immunological impact of repeated pulmonary exposure to Cryptococcus yeasts.

Methods

Mice were repeatedly exposed to an immunogenic dose of C. neoformans or V. victoriae via oropharyngeal aspiration. Bronchoalveolar lavage fluid (BALF) and lungs were collected to examine airway remodeling, inflammation, mucous production, cellular influx, and cytokine responses at 1 day and 21 days post final exposure. The responses to C. neoformans and V. victoriae were analyzed and compared.

Results

Following repeated exposure, both C. neoformans and V. victoriae cells were still detectable in the lungs 21 days post final exposure. Repeated C. neoformans exposure initiated myeloid and lymphoid cellular infiltration into the lung that worsened over time, as well as an IL-4 and IL-5 response compared to PBS-exposed controls. In contrast, repeated V. victoriae exposure induced a strong CD4+ T cell-driven lymphoid response that started to resolve by 21 days post final exposure.

Discussion

C. neoformans remained in the lungs and exacerbated the pulmonary immune responses as expected following repeated exposure. The persistence of V. victoriae in the lung and strong lymphoid response following repeated exposure were unexpected given its lack of reported involvement in AAD. Given the abundance in indoor environments and industrial utilization of V. victoriae, these results highlight the importance to investigate the impact of frequently detected fungal organisms on the pulmonary response following inhalational exposure. Moreover, it is important to continue to address the knowledge gap involving Basidiomycota yeasts and their impact on AAD.